CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +6,179 | $4.70 | $29K | 154,300 |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +27,333 | $9.41 | $257K | 181,633 |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −33,512 | $25.03 | $839K | 148,121 |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,179 | 37,224 | ||
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −27,333 | 53,300 | ||
| 2026-08-19 | Chao Xingjuan President and CEO | Sale 10b5-1 | −31,415 | $25.03 | $786K | 787,799 |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +690 | $4.70 | $3K | 148,811 |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +300 | $9.41 | $3K | 149,111 |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −990 | $25.00 | $25K | 148,121 |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −690 | 43,403 | ||
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −300 | 80,633 | ||
| 2026-08-18 | Chao Xingjuan President and CEO | Sale 10b5-1 | −2,199 | $25.00 | $55K | 819,214 |
| 2026-08-13 | Chao Xingjuan President and CEO | Option exercise | +8,096 | $2.24 | $18K | 796,413 |
| 2026-08-13 | Chao Xingjuan President and CEO | Option exercise | +25,000 | $3.65 | $91K | 821,413 |
| 2026-08-13 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) | −8,096 | 0 | ||
| 2026-08-13 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) | −25,000 | 188,100 | ||
| 2026-08-13 | Taylor Joseph Michael Director | Sale | −13,095 | $23.40 | $306K | 48,478 |
| 2026-08-03 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +1,446 | $4.70 | $7K | 803,763 |
| 2026-08-03 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +23,554 | $4.70 | $111K | 827,317 |
| 2026-08-03 | Chao Xingjuan President and CEO | Sale 10b5-1 | −39,000 | $18.32 | $714K | 788,317 |
Page 3 of 17 · 330 trades